作者: Hiroyoshi Takamura
DOI: 10.1016/J.TETLET.2018.02.004
关键词:
摘要: A variety of natural products, a valuable source drug lead compounds, coexist with their stereoisomers as congeners. For pursuing the structural elucidation and structure–activity relationship study it is needed to establish streamlined synthetic route supply products stereoisomers. Divergent pathway one strategies deliver more than target compound. In this digest, selected examples stereodivergent approach toward synthesis are described. Especially, digest focuses on common intermediates stereodiversification steps from reach compounds.